Author Index: K

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
COST-EFFECTIVENESS OF TELEHOMECARE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CANADA

PREDICTING UTILITY SCORES FOR MYELOFIBROSIS PATIENTS: MAPPING THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM AND MYELOPROLIFERATIVE SYMPTOM ASSESSMENT FORM TO THE EUROQOL-5D

CURRENT TREATMENT FOR CHRONIC HEPATITIS B (CHB): A SYSTEMATIC REVIEW AND A NETWORK META-ANALYSIS

BURDEN OF COMMUNITY-ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION IN ONTARIO, CANADA: A POPULATION-BASED STUDY

A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

ONE YEAR HEALTHCARE COST AND UTILIZATION IN ADULTS WITH CHRONIC PAIN

ESTIMATION OF FIBROSIS PROGRESSION RATES FOR CHRONIC HEPATITIS C: A SYSTEMATIC REVIEW AND META-ANALYSIS UPDATE

IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM

IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS

IMPACT OF TELEHOMECARE PROGRAM ON PATIENTS' QUALITY OF LIFE AND DISEASE-MANAGEMENT SKILLS

NEW MODEL OF HEALTHCARE DELIVERY-TELEHOMECARE PROGRAM FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND HEART FAILURE (HF) PATIENTS IN ONTARIO, CANADA

FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO

SOCIAL MEDIA AS A KEY TOOL TO RECRUIT RARE DISEASE PATIENTS FOR CLINICAL RESEARCHERS

COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS

MANAGEMENT OF EPILEPSY IN WOMEN CONTEMPLATING PREGNANCY: A DECISION ANALYSIS MODEL

HEALTH UTILITIES IN ADULTS WITH CHRONIC PAIN
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z